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Abstract
Hirschsprung disease (HSCR) exhibits complex genetics with incomplete penetrance and variable severity thought to result
as a consequence of multiple gene interactions that modulate the ability of enteric neural crest cells to populate the
developing gut. As reported previously, when the same null mutation of the Ednrb gene, Ednrb
sl, was introgressed into the
F344 strain, almost 60% of F344-Ednrb
sl/sl pups did not show any symptoms of aganglionosis, appearing healthy and
normally fertile. These findings strongly suggested that the severity of HSCR was affected by strain-specific genetic factor (s).
In this study, the genetic basis of such large strain differences in the severity of aganglionosis in the rat model was studied
by whole-genome scanning for quantitative trait loci (QTLs) using an intercross of (AGH-Ednrb
sl6F344-Ednrb
sl)F 1 with the
varying severity of aganglionosis. Genome linkage analysis identified one significant QTL on chromosome 2 for the severity
of aganglionosis. Our QTL analyses using rat models of HSCR revealed that multiple genetic factors regulated the severity of
aganglionosis. Moreover, a known HSCR susceptibility gene, Gdnf, was found in QTL that suggested a novel non-coding
sequence mutation in GDNF that modifies the penetrance and severity of the aganglionosis phenotype in EDNRB-deficient
rats. A further identification and analysis of responsible genes located on the identified QTL could lead to the richer
understanding of the genetic basis of HSCR development.
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Introduction
Hirschsprung disease (HSCR) is a congenital malformation
characterized by the absence of intramural ganglion cells along
variable lengths of the distal gut. Due to the lack of ganglia, the
stool cannot be passed through the colon, and the bowel wall is
dilated [1–4]. The disorder is classified into short-segment (S-
HSCR, 80%), long-segment (L-HSCR, 15%), or total colonic
aganglionosis (TCA, 5%) [5]. HSCR is observed in about 1/5000
live birth and is more frequent in males than in females (4:1), a
difference most prominent in S-HSCR [6]. Several genes have
been implicated in the development of HSCR, including the RET
proto-oncogene [7–9], endothelin receptor B gene (EDNRB) [10–
17], endothelin-3 gene (EDN3) [18,19], glial-cell-line-derived
neurotrophic factor (GDNF) [20–22], SOX10 [23,24], NRTN
[25], ECE1 [26], ZFHX1B [27], PHOX2B [28], KIAA1279 [29],
TCF4 [26]. However, mutations in these genes explain only a
minority of cases and the vast majority (80%) of HSCR heritability
remains unknown [30]. HSCR displays a highly variation in
penetrance and phenotypes by gender, familial incidence, segment
length of aganglionosis and associated phenotypes. The variable
penetrance and expressivity of this disease are attributed to the
complex genetic interactions between the known susceptibility loci
and undiscovered susceptibility or modifier loci in the genetic
background that modulates the ability of enteric neural crest cells
to populate the developing gut [31].
Many researchers have used inbred models to search the un-
known susceptibility or modifier genes of aganglionosis [31,32].
Moreover, mouse models, in which genetic background and input
alleles can be controlled in genome-wide and candidate gene
approaches, are a strong tool to identify the novel genetic factors or
modifiers that influence the variable penetrance and inheritance
patterns of complex diseases like HSCR. Spotting lethal (sl)i sa
spontaneous null mutation that has a 301 bp deletion in the rat
Ednrb gene that results in the absence of a functional receptor
protein [33]. In the previous study, we established an AGH-Ednrb
sl
[34] inbred strain carrying the sl mutation, further, introgressed this
mutation into LEH and F344 strains to produce two congenic
strains: LEH-Ednrb
sl and F344-Ednrb
sl [34]. In AGH-Ednrb
sl/sl rats,
only 20% of pups survived until weaning; whereas in F344-Ednrb
sl/sl
rats, 100% of pups survived to weaning. Interestingly, almost 60%
of F344-Ednrb
sl/sl pups did not show any symptoms of aganglio-
nosis, appearing healthy and normally fertile and showing normal
body weight gain. Thus, we concluded that variation in the
penetrance and survival was attributable to distinct differences in
the severity of aganglionosis, and resistant genes in the genetic
background of F344 significantly modulated the severity of the
aganglionosis phenotype.
This study focuses on the variation in aganglionosis between
individual Ednrb
sl-mutated rats and uses this variation to identify
modifiers that are influencing the aganglionosis aspect of the
phenotype. These studies have been facilitated by the ability to
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sl rats that are
not possible in patient studies.
Results
Evaluation of aganglionosis as a quantitative trait in F2
Ednrb
sl/sl rats
Homozygous Ednrb
sl/sl rats showed aganglionosis phenotypes. In
our previous study, we found that when the sl mutation was
introgressedintotheF344strain,thephenotype ofaganglionosiswas
strongly modified [34]. As shown in Fig. 1, AGH-Ednrb
sl/sl rats at
postnatal 14 day exhibited abnormal dilation of the intestines
resulting from the absence of ganglion cells in a long segment
beyond caecum. In contrast, in F344-Ednrb
sl/sl pups at postnatal 14
day, an enlarged small intestinal phenotype (mega small intestine)
was not found. We have confirmed that the variation in the
expressivityofthisdiseasebetweenthesetwostrainswascausedfrom
the extent of aganglionosis by whole-mount acetylcholinesterase
(AChE) staining [34]. We used the same method to establish the
range of phenotypes among the F2 (AGH6F344) Ednrb
sl/sl
progenies.TheF2 animals(n=410)wereproducedbyheterozygotes
mating between AGH and F344 strains and then 96 Ednrb
sl/sl pups
were selected to phenotype based on the difference in skin
pigmentation pattern between homologous mutants and other
genotype rats or genotyping for the Ednrb
sl mutation (for albino
pups). The number of Ednrb
sl/sl pups was consistent with the
anticipated 25% transmission ratio. Microscopic examination of
Ednrb
sl/sl intestines stained by AChE was used to appraise the length
of aganglionosis gut, then the extent of aganglionosis was calculated
as a ratio of length of the aganglionosis intestine to the length of the
entire large intestine used as a quantitative trait in individual
animals. We also recorded the gross intestine weight and body
weightofpupsatpostnatal14day,andtofullycapturethedifference
between sick and healthy ones, the ratio of gross intestine weight
(gross intestine weight/body weight) was calculated, which demon-
strates the expressivity of megacolon directly. We found that there
was a high correlation between the aganglionosis extent and the
ratio of gross intestine weight in F2 populations (Fig. 2). This showed
that the ratio of aganglionosis extent is appropriate as a quantitative
trait for the severity of aganglionosis. The specificity and sensitivity
of the extent of aganglionosis as a quantitative trait were confirmed
by following experiments using MapManager QTXb.
The range of the aganglionosis extent for each progeny is
presented as black characters in Fig. 3A, which was fairly scattered
for F2 intercross progenies, while that of the AGH and F344
progenies tended to fall on one of the two extremes. The mean
ratio of the F2 progenies (0.95 in ratio of aganglionosis extent)
composed of each homozygote of AGH and F344, and the
heterozygotes were nearly the same as that of the F1 progenies
(1.08 in ratio of aganglionosis extent).
In Fig. 3B and 3C, individual traits of the male and female F2
progenies are arranged by size of the ratio of aganglionosis extent.
The trait-value graphs in both males and females showed similar
gentle curves, which suggests that the mild aganglionosis extent in
F344- Ednrb
sl/sl rats are under the control of polygenic inheritance.
QTL analysis identifies modifiers of aganglionosis severity
in Ednrb
sl/sl rats
Final results of interval mapping were considered suggestive,
significant, or highly significant linkages when the threshold likelihood
ratio statistics (LRS) were 9.9, 20.2, and 30.4, respectively. As shown in
Fig. 4, the highest linkage over the significant level (LRS.20.2)
appeared on Chr 2. The maximum LRS score was 23.9 on Chr 2.
Linkage details were shown in Fig. 5. The locus at the D2Mit5 marker
Figure 1. Comparison of the expressivity of aganglionosis. 14-
day-old AGH-Ednrb
sl/sl rats (left) show severe symptoms of aganglio-
nosis, but not in F344-Ednrb
sl/sl rats (right).
doi:10.1371/journal.pone.0027902.g001
Figure 2. Correlation analysis between the severity of agan-
glionosis and the ratio of gross intestine weight. Correlation
analysis between the severity of aganglionosis (aganglionosis length/
large intestine length) and the ratio of gross intestine weight (gross
intestine weight/body weight) shows a high correlation between the
two traits.
doi:10.1371/journal.pone.0027902.g002
QTL Analysis for Modifier Loci of Aganglionosis
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(LRS=23.9), was designated ‘Lrag1 (Locus of resistance to aganglionosis 1)’.
The epistatic interaction between markers also was searched by
MapManager QTXb, but no significant interaction was found.
Allele effects of Ednrb
sl/sl modifier loci
Modifier loci either can increase susceptibility and severity of
phenotype or can act protectively to confer resistance to disease in
the face of a predisposing mutation [35]. To assess the effects of
individual Ednrb
sl/sl modifiers on the severity of aganglionosis, we
evaluated complete genotype information in the total F2 dis-
tribution. F344 alleles at modifier locus on chromosome 2
decreased the extent of gut length affected by aganglionosis
(Fig. 6). The allele effect observed was approximately dominant,
with heterozygotes exhibiting phenotypes equal to the phenotypes
of the homozygous animals of F344 alleles.
Figure 3. The range of the aganglionosis extent. (A) Therange of the aganglionosis extent in 14-dayold pups from AGH-Ednrb
sl/sl, F344-Ednrb
sl/sl,
F1, and F2. Mean values are indicated by horizontal lines. Distribution of the severity of aganglionosis in male (B) and female (C) F2 progenies.
doi:10.1371/journal.pone.0027902.g003
Figure 4. Result of interval mapping scans by MapManager QTXb in F2 rats. Analyses of linkage of aganglionosis severity in F2 populations
to chromosomal loci were performed using the MapManager QTXb20 software. Recombination frequencies (%) were converted into genetic distance
(centiMorgan; cM) using the Kosambi map function, in which linkage data are provided as likelihood ratio statistic (LRS) scores. Genome-wide
significance thresholds were calculated in terms of LRS by carrying out permutation tests for 500 permutations. The thresholds for suggestive (Su),
significant (Si) linkages are indicated in dotted and thin lines, respectively. LRS, likelihood ratio statistic.
doi:10.1371/journal.pone.0027902.g004
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By bioinformatics methods combining genome annotation with
literature searches, some biologically relevant genes within
modifier intervals have been identified successfully [36]. We used
the positions of the closest markers flanking the peak on Chr 2 to
define the boundaries of this interval on the rat genome assembly
and searched for genes that might be involved in development of
enteric neural system based on their expression profiles in the
literature and public databases. More than 30 genes within this
interval were identified by NCBI. This listing of candidates was
narrowed to include only those genes associated with cell
migration, the development of enteric nervous system based on
information in the PosMed and in the Gene Expression Database
(Table 1). Within these genes, two highly relevant candidates were
identified based on their documented expression in the developing
gut. These included Gdnf and Rai14 genes. Rai14 is expressed early
in the neural tube of 9.5-day mouse embryo and maintained in
intestines. Gdnf encodes a highly conserved neurotrophic factor,
which promotes the survival of many types of neurons. Gdnf-null
mice showed a complete absence of the enteric nervous system,
ureters, and kidneys [37]. GDNF is established to be important in
the development of the enteric nervous system and Hirschsprung
disease. So it is a logical and possible candidate modifier. We
sequenced the coding region of Gdnf, but failed to find a difference
between the two rat strains. Subsequently, we also compared the
expression level of Gdnf mRNA of the whole intestine tissue from
wildtype and heterozygous AGH and F344 rats in embryonic day
15.5 by RT-PCR. However, no difference was found (data not
shown).
Discussion
The enteric nervous system (ENS) mostly derives from mig-
ratory vagal neural crest cells. A minority of the foregut ENS also
arise from migratory anterior trunk neural crest cells of the
posterior vagal region [4]. Neural crest cells enter the foregut at
embryonic day 9–9.5 in mice, in this time they are termed enteric
neural crest-derived cells (ENCCs) [4]. These progenitor cells of
enteric nervous system migrate in a rostral to caudal direction to
sequentially colonize the foregut, midgut, and last the hindgut,
which is complete by embryonic day 15 [2,4]. Neural crest cells
from sacral levels of the neural tube also colonize the gut, where
they contribute to only a small fraction of enteric neurons and glia
in the distal midgut and hindgut [2,4]. ENCCs proliferate actively
to expand the relatively small pool of progenitors and then
differentiate into phenotypically distinct neuronal subtypes and
glia. The multi-step, complex nature of ENS ontogeny suggests
that it is vulnerable to alterations in the function or expression of
many genes as well as changes in the environment. When this
progress is disturbed, a congenital gut motility disorder, HSCR
occurs, which is characterized by an absence of enteric neurons in
terminal regions of the gut. HSCR is a complex disease mani-
festing with low, sex-dependent penetrance and variability in the
length of the aganglionic segment [32].
In human with HSCR, the genetic interaction between
mutations in RET and EDNRB was found in an association study
conducted on Mennonite family with the W276C mutations in the
EDNRB [38]. The combination of these two genotypes increased
Figure 5. Details of suggestive and significant linkages in QTL
analysis of the severity of aganglionosis. The QTL on chromo-
somes 2 (Lrag1) showed a significant linkage to aganglionosis severity,
respectively. The dotted and thin lines represent suggestive (Su) and
significant (Si) thresholds, respectively. The microsatellite markers used
for determining genotypes of F2 rats are presented along the X-axis.
LRS, likelihood ratio statistic.
doi:10.1371/journal.pone.0027902.g005
Figure 6. Effect of alleles at Ednrb
sl/sl modifier loci on the
severity of aganglionosis. Genotypes from the total F2 population
obtained from the marker closest to the modifier were used to assess
the effects of individual loci on the severity of phenotype. The mean of
aganglionosis severity (aganglionosis length/large intestine length) is
plotted for each genotype class to show the relation of the number of
AGH or F344 alleles and the extent of aganglionosis for this locus.
Markers used to generate genotype information are listed beneath the
plot. Genotype groups are defined as AGH/AGH (AA), AGH/F344 (AF)
and F344/F344 (FF).
doi:10.1371/journal.pone.0027902.g006
Table 1. List of candidate genes for Lrag1.
Lrag1 candidates on Chr 2
Gene symbol Gene description Mbp
D2Arb7 Flanking marker 57.2
Gdnf Glial cell line-derived neurotrophic factor 57.4
Rai14 Retinoic acid induced 14 59.9
Zfr Zinc finger RNA-binding protein 61.6
Mtmr12 Myotubularin-related protein 12 61.6
Mtmr1 Myotubularin related protein 1 61.7
Golph3 Golgi phosphoprotein 3 61.8
Pdzd2 PDZ domain containing 2 61.8
D2Mit5 Flanking marker 66.7
doi:10.1371/journal.pone.0027902.t001
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disease. Genetic interaction between RET and EDNRB pathways
has also been demonstrated in mice [38–40]. In mice, heterozy-
gosity for two known mutant HSCR genes, RET
+/2 and Ednrb
sl,o r
RET
+/2 and Ednrb
s genes, had no intestinal aganglionosis, whereas
RET
+/2 mice with the homozygous Ednrb
s or heterozygous Ednrb
s/
Ednrb
sl mutations showed megacolon [38,40]. Thus, the synergistic
effects of multiple mutations in HSCR-associated genes can
influence disease penetrance and expressivity. The mechanisms
underlying these interaction may help to explain the complexity of
the HSCR phenotype and resolve puzzling genetic observations,
such as variations in penetrance and severity of aganglionosis
between family members carrying equivalent mutations in HSCR
genes [41]. However, many susceptibility genes or modifier genes
or interaction between them remain unknown. Animal models
have greatly helped us to understand HSCR genetics and em-
bryologic events that construct the ENS. Several susceptibility
genes of HSCR are initially identified in mice that are later found
to be altered in human HSCR patients [42,43].
In this study, we used quantitative trait locus (QTL) mapping to
detect the genetic loci that contribute to differences in phenotypic
variation of aganglionosis extent between F344 and AGH strains
with the same null mutations. Using this comprehensive approach,
we have successfully identified a modifier locus of Ednrb
sl/sl on
rat chromosomes 2. This locus contains a known aganglionsis
susceptibility gene, GDNF. The GDNF ligand activates the RET
receptor through the assembly of a multiprotein complex, inclu-
ding the GDNF family receptor alpha1 (GFRalpha1) molecule, which
have important functions in the development and maintenance of
sensory, enteric, sympathetic and parasympathetic neurons and a
variety of non-neural tissues [44]. The genetic interaction between
mutations in RET and EDNRB has been well described in human
patients and confirmed in mice [38–40]. So it is possible that there
was an interaction between Gdnf ligand and Ednrb. Though we
failed to find the sequence difference of coding region in Gdnf gene
between both rat strains, we cannot completely exclude the
possibility that Gdnf is a responsible gene because the non-coding
regulatory region of Gdnf remains unknown which could affect the
Gdnf expression in a specific timing that is important for the ENS
development. Such case has been found in human with HSCR
that a non-coding RET variant within a conserved enhancer-like
sequence in intron 1 is significantly associated with HSCR sus-
ceptibility [45]. We only investigated the expression level of Gdnf in
embryonic day 15.5. It remains unknown whether there is
difference in the expression level at other developmental stage of
ENS. The spacial and temporal control of gene expression in the
complex process of ENCCs colonization of the gut is very
important. Ednrb is genetically required in the mouse for ENS
development in vivo from embryo day 10 to embryo day 12.5 [46].
The interaction of RET and EDNRB signaling pathways only
influenced the ENS, no impact on melanocyte, retinal choroid,
and kidney development, which showed a tissue-specific interac-
tion [40]. All these lines of evidence suggested a possibility that a
non-coding variant of Gdnf interacting with Ednrb mutation in
AGH strain resulted in the serious aganglionosis.
Using congenic techniques, we are currently attempting to
generate rat strains that harbor QTLs from one selection line on
the opposite line to investigate whether each allele has a different
effect on the phenotype. At the same time, several approaches are
currently being employed to identify candidate genes located on
Lrag1. Some of these approaches include comparisons of gene
expression levels of F344 and AGH rats in intestine tissues using
microarray and next-generation RNA sequencing technologies.
This analytical combination that includes QTL mapping and gene
expression profiles has proven useful in the selection of candidate
genes.
A lack of existing comprehensive information on the suscepti-
bility genes and interaction between susceptibility loci or modifier
loci contributing to HSCR disease in the genetic background
makes it difficult to understand the genetic base for many cases of
HSCR. However, our study localized chromosomal sites where
the allelic differences in genes presented in F344 and AGH rats
and strongly affected the occurrence and severity of HSCR using
QTL analysis. This study provided the new evidence that Hir-
schsprung disease is the consequence of multiple gene interactions
that modulate the ability of enteric neural crest cells to populate
the developing gut.
Materials and Methods
Animals
Heterozygous AGH/Hkv-Ednrb
sl (AGH) [34] and F344-Ednrb
sl
(F344) [34] rats were bred to generate F2 animals (n=410), in
which 96 Ednrb
sl/sl pups were selected to phenotype based on the
difference in skin pigmentation pattern. Namely, heterozygous
AGH-Ednrb
sl rats had pigmented heads, backs, and tails. In
contrast, homozygous mutant rats had almost no pigmentation on
their heads previously described [34]. On the other hand, since
F344 is an albino (tyrosinase mutant) strain, albino F2 rats were
genotyped to distinguish homozygote from heterozygote and
wildtype by PCR. Animals were genotyped for Ednrb
sl mutation
using primers (F-CCTCCTGGACTAGAGGTTCC and R-AC-
GACTTAGAAAGCTACACT) that flank the site of the 301-base
deletion. PCR products were electrophoresed in 2% agarose gels
to distinguish the wild (511 bp) and mutant (210 bp) alleles. To
determine the aganglionosis extent by strain, AGH (n=33), F344
(n=35), F1 (n=32) were raised. Animals were maintained in
specific pathogen-free conditions with feeding and drinking al-
lowed ad libitum. All research and experimental protocols were
conducted according to the Regulation for the Care and Use of
Laboratory Animals of Hokkaido University and were approved
by the Animal Care and Use Committee of Hokkaido University
(Approval ID: No. 110226).
Microsatellite genotyping
The genome-wide scan was performed using 96 intercross
progenies. Genomic DNA was extracted from tail clips of these
intercross progenies using a standard protocol and was subjected
to a genome-wide scan at 10–30 Mbp resolution using 94 poly-
morphic microsatellite markers (Table 2). PCR primers of the
markers were identified in the Rat Genomic Database of Ensembl
(http://uswest.ensembl.org). Amplified samples were electropho-
resed in 10% acrylamide gels, stained with ethidium bromide, and
photographed under an ultraviolet lamp.
Whole-mount staining
The guts from pups at postnatal day 14 were dissected as a
single piece from the proximal esophagus to the distal colon.
Mesenteric attachments and the pancreas were removed, and the
guts were then processed for acetylcholinesterase (AChE) whole-
mount staining using routine protocols to visualize enteric ganglia
[31]. The extent of the gut regions affected by aganglionosis was
determined by microscopic examination. The entire length of the
gut and the large intestine length, as well as any aganglionic
regions, were measured. The length of the aganglionic segment
was divided by the whole large intestine length to yield an
aganglionosis ratio.
QTL Analysis for Modifier Loci of Aganglionosis
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To identify the aganglionosis modifier loci, genotyping data and
the ratio of aganglionosis extent were analyzed by MapManager
QTXb [47], whereby permutation tests were done in 1-cM steps
for 500 permutations to determine the suggestive, significant, or
very significant levels of statistics.
Statistical analyses
For comparison of allele effect at Ednrb
sl modifier loci, the t-test
was performed to compare the mean values for data sets.
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AFF2: (AGH-Ednrb
sl6F344-Ednrb
sl)F 2.
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